Intragastric Balloon With Lifestyle Intervention vs. Lifestyle Intervention in Obese Patients With NASH
NCT03538236 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2021-03-30
Summary
The primary objective of this study is to assess efficacy of intragastric balloon for weight loss in obese patients who also concurrently have NASH.
Conditions
- Obesity
- NASH - Nonalcoholic Steatohepatitis
- Obesity, Morbid
Interventions
- DEVICE
-
Intragastric balloon
Intragastric balloon insertion will be performed by an endoscopist under monitored anesthesia care. The Intragastric BalIoon (GB) comes as a deflated balloon pre-loaded on a catheter, which is inserted transorally into the proximal gastric body. An endoscope is then inserted alongside the device allowing for direct visualization of the balloon. Once in place, the intragastric balloon will be filled with saline through an external port. The balloon is inserted for 6 months then retrieved endoscopically
- BEHAVIORAL
-
Lifestyle intervention
All patients included in the study will undergo an evaluation by a nutritionist. All participants will receive recommendations for a diet. Participants will be instructed to keep a daily food diary and will meet with the nutritionist to reinforce the behavior every 12 weeks for 12 months.
Sponsors & Collaborators
-
ReShape Lifesciences
collaborator INDUSTRY - lead OTHER
Principal Investigators
-
Vivek Kumbhari, MD · Johns Hopkins University
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-03-01
- Primary Completion
- 2022-05-30
- Completion
- 2022-05-30
- FDA Device
- Yes
More Related Trials
-
A Prospective Multicenter Post Approval Study of the ReShape™ Integrated Dual Balloon System in Obese Subjects
NCT02927665 ·Status: UNKNOWN
-
Gastric Bypass Stent Small-Sample-Size Study For Nonalcoholic Fatty Liver Disease
NCT05495139 ·Status: RECRUITING ·Phase: NA
-
Gastric and Autonomic Functions in Patients With Intragastric Balloon
NCT03530410 ·Status: WITHDRAWN
-
Effect of Gastric Balloon in Morbid Obesity: Prospective Study
NCT02128165 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Endoscopic Gastric Plication Using the POSE2.0 Technique for Management of Fatty Liver Disease
NCT05611567 ·Status: COMPLETED ·Phase: NA
-
Surgical Intervention in Bariatric Patients: Excess Weight Loss in the Morbidly Obese Following Gastric Plication
NCT01077193 ·Status: TERMINATED ·Phase: NA
-
ReShape Intragastric Balloon for the Treatment of Obesity
NCT01024465 ·Status: COMPLETED ·Phase: NA
-
Effectiveness Gastric Balloon in Obese Adolescents
NCT04209842 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Controlled Trial of WLS vs. CLI for Severely Obese Adolescents With NASH
NCT02412540 ·Status: COMPLETED ·Phase: NA
-
Pivotal Aspiration Therapy With Adjusted Lifestyle Therapy Study
NCT01766037 ·Status: COMPLETED ·Phase: NA
-
Endoscopic Gastric Mucosal Ablation as a Primary Obesity Therapy
NCT05486338 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss
NCT07237750 ·Status: RECRUITING ·Phase: NA
-
Comparative Study of Intragastric Balloon and Pharmacotherapy for Non-Morbid Obesity
NCT00355979 ·Status: UNKNOWN ·Phase: PHASE3
-
Study to Evaluate Novel Gastric Space Occupying Device
NCT01288456 ·Status: COMPLETED
-
Outcome of Combined Botulinum Toxin A Injection and Gastric Balloon Implantation in Obesity Treatment
NCT05872932 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of the Safety and Effectiveness of Stomaphyx for Transoral Incisionless Reduction of the Enlarged Gastric Pouch and Stoma
NCT01025076 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Harmonic Scalpel and Ligasure Devices in Laparoscopic Morbid Obesity Surgery
NCT02538328 ·Status: COMPLETED ·Phase: NA
-
EFFICACY OF THE SLEEVE GASTROPLASTY WITH THE ENDOSCOPIC SYSTEM OVERSTICH SX ON WEIGHT LOSS AND REDUCTION OF CO-MORBIDITY FOR OBESE PATIENTS
NCT05072067 ·Status: COMPLETED ·Phase: NA
-
Pilot Study on The Flanks of Asian Patients
NCT01623037 ·Status: COMPLETED ·Phase: NA
-
Prospective Study Of The Procedure-less Intra-gastric Elipse Balloon: Is It Effective & Safe?
NCT03160469 ·Status: COMPLETED ·Phase: NA
-
Endoscopic Sleeve Gastroplasty (ESG) for the Treatment of Obesity
NCT06339320 ·Status: RECRUITING ·Phase: NA
-
Evaluation of a Powered Stapler System on Surgical Interventions Required During Laparoscopic Sleeve Gastrectomy
NCT02358785 ·Status: COMPLETED
-
European Study to Evaluate Preliminary Safety and Efficacy of Multiple Obalon Gastric Balloons for 12 Weeks as an Aid for Weight Loss
NCT01718886 ·Status: COMPLETED
-
Impact of Discontinuing GLP-1 Receptor Agonists for Two Weeks Prior to Upper Endoscopy on the Risk of Gastric Retention
NCT07276763 ·Status: NOT_YET_RECRUITING
-
Laryngeal Masks for Bariatric Surgery
NCT01724970 ·Status: UNKNOWN ·Phase: PHASE3